Cargando…

Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia

Glial fibrillary acidic protein (GFAP) has been suggested as a biomarker for reactive astrogliosis. We measured the levels of plasma GFAP by Simoa in 60 patients with PD with normal cognition, 63 with mild cognitive impairment (PD-MCI), 24 with dementia (PDD) and 15 healthy controls. A subgroup of p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Yilin, Han, Linlin, Li, Shiyu, Hu, Tianyu, Xu, Zhiheng, Fan, Yun, Liang, Xiaoniu, Yu, Huan, Wu, Jianjun, Wang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911758/ https://www.ncbi.nlm.nih.gov/pubmed/36759508 http://dx.doi.org/10.1038/s41531-023-00447-7

Ejemplares similares

Association of the serum microRNA-29 family with cognitive impairment in Parkinson's disease
por: Han, Linlin, et al.
Publicado: (2020)

Quality of life: Seasonal fluctuation in Parkinson's disease
por: Wu, Lei, et al.
Publicado: (2023)

Determinants of quality of life in Parkinson’s disease: a perspective of novel clinical subtypes
por: Fan, Yun, et al.
Publicado: (2021)

Determinants of Quality of Life According to Cognitive Status in Parkinson’s Disease
por: Fan, Yun, et al.
Publicado: (2020)

Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia
por: Tien, Yi-Ting, et al.
Publicado: (2019)

Incidence of Mild Cognitive Impairment, Conversion to Probable Dementia, and Mortality
por: Zhang, Yun, et al.
Publicado: (2021)

A population‐based meta‐analysis of circulating GFAP for cognition and dementia risk
por: Gonzales, Mitzi M., et al.
Publicado: (2022)

Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
por: Nicoletti, Alessandra, et al.
Publicado: (2019)

Rapidly progressive dementia: Extending the spectrum of GFAP‐astrocytopathies?
por: Friedrich, Maximilian, et al.
Publicado: (2022)

Microbleeds in fronto-subcortical circuits are predictive of dementia conversion in patients with vascular cognitive impairment but no dementia
por: Chen, Yang-Kun, et al.
Publicado: (2018)

Intranasal Delivery of Bone Marrow Stromal Cells Preconditioned with Fasudil to Treat a Mouse Model of Parkinson’s Disease
por: Tang, Yilin, et al.
Publicado: (2020)

Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson’s Disease
por: Tang, Yilin, et al.
Publicado: (2016)

Heath management app use in Parkinson’s disease and quality of life during the COVID-19 pandemic
por: Tang, Yilin, et al.
Publicado: (2023)

The Genetic Basis of Cognitive Impairment and Dementia in Parkinson’s Disease
por: Collins, Lucy M., et al.
Publicado: (2016)

Imaging Mild Cognitive Impairment and Dementia in Parkinson's Disease
por: Sasikumar, Sanskriti, et al.
Publicado: (2020)

Neuropsychiatric symptoms and faster progression of cognitive impairments as predictors of risk of conversion of mild cognitive impairment to dementia
por: Bidzan, Mariola, et al.
Publicado: (2017)

Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer’s disease-associated biomarkers alterations among de novo Parkinson’s disease patients: a prospective cohort study
por: Liu, Tingting, et al.
Publicado: (2023)

Neuropsychiatric Symptoms in Parkinson's Disease with Mild Cognitive Impairment and Dementia
por: Leroi, Iracema, et al.
Publicado: (2012)

Immunoreactivity to astrocytes in different forms of dementia: High prevalence of autoantibodies to GFAP
por: Barthel, Paula Charlotte, et al.
Publicado: (2023)

Plasma proteomic signatures predict dementia and cognitive impairment
por: Tanaka, Toshiko, et al.
Publicado: (2020)

Cognitive Profiles of Patients with Mild Cognitive Impairment or Dementia in Alzheimer's or Parkinson's Disease
por: Hildebrandt, Helmut, et al.
Publicado: (2013)

GFAP at 50
por: Messing, Albee, et al.
Publicado: (2020)

Systemic Oxidative Stress and Conversion to Dementia of Elderly Patients with Mild Cognitive Impairment
por: Cervellati, Carlo, et al.
Publicado: (2014)

Association between physical activity and conversion from mild cognitive impairment to dementia
por: Kim, Yeo Jin, et al.
Publicado: (2020)

Neuropsychological predictors of conversion from mild cognitive impairment to dementia at different timepoints
por: Quaranta, Davide, et al.
Publicado: (2023)

Prognostic relevance of gait-related cognitive functions for dementia conversion in amnestic mild cognitive impairment
por: Tuena, Cosimo, et al.
Publicado: (2023)

Dopaminergic and Metabolic Correlations With Cognitive Domains in Non-demented Parkinson’s Disease
por: Han, Linlin, et al.
Publicado: (2021)

Complement protein levels in plasma astrocyte-derived exosomes are abnormal in conversion from mild cognitive impairment to Alzheimer's disease dementia
por: Winston, Charisse N., et al.
Publicado: (2019)

Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson’s disease
por: Gschmack, Eva, et al.
Publicado: (2022)

Cognitive Impairment in Parkinson's Disease without Dementia: Subtypes and Influences of Age
por: Kim, Jae Woo, et al.
Publicado: (2009)

Cognitive Impairment and Dementia in Parkinson’s Disease: Clinical Features, Diagnosis, and Management
por: Meireles, Joana, et al.
Publicado: (2012)

Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias
por: Baiardi, Simone, et al.
Publicado: (2022)

Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies()
por: Bonanni, Laura, et al.
Publicado: (2015)

Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer’s dementia
por: Zhao, Aonan, et al.
Publicado: (2020)

Frontal-executive dysfunction affects dementia conversion in patients with amnestic mild cognitive impairment
por: Jung, Young Hee, et al.
Publicado: (2020)

Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis
por: Roberto, Natalia, et al.
Publicado: (2021)

Predictors of Conversion to Dementia in Patients With Mild Cognitive Impairment: The Role of Low Body Temperature
por: Alagiakrishnan, Kannayiram, et al.
Publicado: (2023)

The Characteristics of Social Network Structure in Later Life in Relation to Incidence of Mild Cognitive Impairment and Conversion to Probable Dementia
por: Zhang, Yun, et al.
Publicado: (2021)

Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
por: Cicognola, Claudia, et al.
Publicado: (2021)

Regulation of GFAP Expression
por: Brenner, Michael, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9c02qfmvaj4udm75ltd8vqq6op